Recent developments in biotechnology highlight key updates from the European Medicines Agency (EMA), the Institute for Clinical and Economic Review (ICER), and a federal appeals court. Unfortunately, specific details from these updates are behind a paywall and are exclusive to STAT+ subscribers. For those interested in keeping informed on the science and politics shaping the biotech sector, signing up for the biotech newsletter is recommended.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.statnews.com/2026/08/17/biotech-news-akeso-summit-ivonescimabs-worsening-tumor-progression-benefit/
